Current Investments
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
Viamet Pharmaceuticals, Inc.
Robert Schotzinger, Morrisville, NC, US
Viamet discovers and develops "best-in-class" small-molecule inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding, using their trade mark Metallophile Technology.